{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:39:14Z","timestamp":1740109154268,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00404-020-05529-y","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T14:02:51Z","timestamp":1586527371000},"page":"1267-1274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study Group"],"prefix":"10.1007","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0148-3193","authenticated-orcid":false,"given":"Ulrich","family":"Canzler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Joachim","family":"L\u00fcck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Neuser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Burges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Harter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Schmalfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnaz","family":"Aminossadati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Mahner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Kommoss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Wimberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacobus","family":"Pfisterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaus","family":"de Gregorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Hasenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Gropp-Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"El-Balat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Jackisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"du Bois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,10]]},"reference":[{"key":"5529_CR1","unstructured":"Robert-Koch-Institut (2017) Krebs in Deutschland 2013\/2014. 11. Ausgabe, Robert-Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg), Berlin. https:\/\/www.rki.de. Accessed 6 Aug 2019"},{"key":"5529_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"5529_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","volume":"103","author":"J Ferlay","year":"2018","unstructured":"Ferlay J, Colombet M, Soerjomataram I et al (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103:356\u2013387","journal-title":"Eur J Cancer"},{"key":"5529_CR4","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A du Bois","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E et al (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u00b4Investigateurs Nationaux Pour les Etudes des Cancers de l\u00b4Ovaire (GINECO). Cancer 115:1234\u20131244","journal-title":"Cancer"},{"key":"5529_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1365-2141.2010.08122.x","volume":"149","author":"CN Harrison","year":"2010","unstructured":"Harrison CN, Bareford D, Butt N et al (2010) British committee for standards in haematology, guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol 149:352\u2013375","journal-title":"Br J Haematol"},{"key":"5529_CR6","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/jama.2015.8515","volume":"314","author":"AI Schafer","year":"2015","unstructured":"Schafer AI (2015) Thrombocytosis. JAMA 314:1171\u20131172","journal-title":"JAMA"},{"key":"5529_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00404-016-4212-9","volume":"295","author":"J Menczer","year":"2017","unstructured":"Menczer J (2017) Preoperative elevated platelet count and thrombocytosis in gynecologic malignancies. Arch Gynecol Obstet 295:9\u201315","journal-title":"Arch Gynecol Obstet"},{"key":"5529_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/archinte.1964.03860100079008","volume":"114","author":"J Levin","year":"1964","unstructured":"Levin J, Conley CL (1964) Thrombocytosis associated with malignant disease. Arch Intern Med 114:497\u2013500","journal-title":"Arch Intern Med"},{"key":"5529_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1053\/j.seminoncol.2014.04.004","volume":"41","author":"AN Davis","year":"2014","unstructured":"Davis AN, Afshar-Kharghan V, Sood AK (2014) Platelet effects on ovarian cancer. Semin Oncol 41:378\u2013384","journal-title":"Semin Oncol"},{"key":"5529_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3109\/09537104.2016.1170112","volume":"27","author":"Z Baranyai","year":"2016","unstructured":"Baranyai Z, J\u00f3sa V, T\u00f3th A et al (2016) Paraneoplastic thrombocytosis in gastrointestinal cancer. Platelets 27:269\u2013275","journal-title":"Platelets"},{"key":"5529_CR11","first-page":"1725","volume":"33","author":"A Mar\u00e1z","year":"2013","unstructured":"Mar\u00e1z A, Fur\u00e1k J, Varga Z et al (2013) Thrombocytosis has a negative prognostic value in lung cancer. Anticancer Res 33:1725\u20131729","journal-title":"Anticancer Res"},{"key":"5529_CR12","doi-asserted-by":"publisher","first-page":"289563","DOI":"10.1155\/2013\/289563","volume":"2013","author":"A Stravodimou","year":"2013","unstructured":"Stravodimou A, Voutsadakis IA (2013) Pretreatment thrombocytosis as a prognostic factor in metastatic breast cancer. Int J Breast Cancer 2013:289563","journal-title":"Int J Breast Cancer"},{"key":"5529_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.1464-410x.2000.00792.x","volume":"86","author":"NP Symbas","year":"2000","unstructured":"Symbas NP, Townsend MF, El-Galley R et al (2000) Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int 86:203\u2013207","journal-title":"BJU Int"},{"key":"5529_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1006\/gyno.2000.5838","volume":"78","author":"E Hernandez","year":"2000","unstructured":"Hernandez E, Donohue KA, Anderson LL et al (2000) The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 78:137\u2013142","journal-title":"Gynecol Oncol"},{"key":"5529_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ygyno.2013.08.032","volume":"131","author":"TS Nj\u00f8lstad","year":"2013","unstructured":"Nj\u00f8lstad TS, Engerud H, Werner HM et al (2013) Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecol Oncol 131:410\u2013415","journal-title":"Gynecol Oncol"},{"key":"5529_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone RL, Nick AM, McNeish IA et al (2012) Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med 366:610\u2013618","journal-title":"N Engl J Med"},{"key":"5529_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00404-008-0673-9","volume":"279","author":"T Gungor","year":"2009","unstructured":"Gungor T, Kanat-Pektas M, Sucak A, Mollamahmutoglu L (2009) The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors. Arch Gynecol Obstet 279:53\u201356","journal-title":"Arch Gynecol Obstet"},{"key":"5529_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ygyno.2011.04.012","volume":"122","author":"M Lee","year":"2011","unstructured":"Lee M, Kim SW, Nam EJ et al (2011) The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer. Gynecol Oncol 122:238\u2013241","journal-title":"Gynecol Oncol"},{"key":"5529_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ygyno.2003.09.002","volume":"92","author":"AJ Li","year":"2004","unstructured":"Li AJ, Madden AC, Cass I et al (2004) The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol 92:211\u2013214","journal-title":"Gynecol Oncol"},{"key":"5529_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ygyno.2013.05.038","volume":"130","author":"SK Allensworth","year":"2013","unstructured":"Allensworth SK, Langstraat CL, Martin JR et al (2013) Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer. Gynecol Oncol 130:499\u2013504","journal-title":"Gynecol Oncol"},{"key":"5529_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.5604\/12321966.1185785","volume":"22","author":"A S\u0142abuszewska-J\u00f3\u017awiak","year":"2015","unstructured":"S\u0142abuszewska-J\u00f3\u017awiak A, Dmoch-Gajzlerska E, Kozakiewicz B, Jakiel G (2015) The prognostic significance of thrombocytosis in ovarian cancer. Ann Agri Environ Med 22:731\u2013735","journal-title":"Ann Agri Environ Med"},{"key":"5529_CR22","first-page":"514","volume":"31","author":"U Kuyumcuoglu","year":"2010","unstructured":"Kuyumcuoglu U, Guzel AI, Celik Y, Erdemo\u011flu M (2010) The association of preoperative thrombocytosis with prognostic factors in malign ovarian tumor. Eur J Gynaecol Oncol 31:514\u2013516","journal-title":"Eur J Gynaecol Oncol"},{"key":"5529_CR23","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1158\/1078-0432.CCR-14-0870","volume":"21","author":"J Bottsford-Miller","year":"2015","unstructured":"Bottsford-Miller J, Choi HJ, Dalton HJ et al (2015) Differential platelet levels affect response to taxane-based therapy in ovarian cancer. Clin Cancer Res 21:602\u2013610","journal-title":"Clin Cancer Res"},{"key":"5529_CR24","first-page":"82","volume":"19","author":"J Menczer","year":"1998","unstructured":"Menczer J, Schejter E, Geva D et al (1998) Ovarian carcinoma associated thrombocytosis. Correlation with prognostic factors and with survival. Eur J Gynaecol Oncol 19:82\u201384","journal-title":"Eur J Gynaecol Oncol"},{"key":"5529_CR25","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2019.30.e5","author":"Q Ye","year":"2019","unstructured":"Ye Q, Cheng J, Ye M et al (2019) Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis. J Gynecol Oncol. https:\/\/doi.org\/10.3802\/jgo.2019.30.e5","journal-title":"J Gynecol Oncol"},{"key":"5529_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.ygyno.2014.01.003","volume":"132","author":"JG Cohen","year":"2014","unstructured":"Cohen JG, Tran AQ, Rimel BJ et al (2014) Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival. Gynecol Oncol 132:556\u2013559","journal-title":"Gynecol Oncol"},{"key":"5529_CR27","first-page":"2991","volume":"23","author":"A Nather","year":"2003","unstructured":"Nather A, Mayerhofer K, Grimm C et al (2003) Thrombocytosis and anaemia in women with recurrent ovarian cancer prior to a second-line chemotherapy. Anticancer Res 23:2991\u20132994","journal-title":"Anticancer Res"},{"key":"5529_CR28","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","volume":"361","author":"MK Parmar","year":"2003","unstructured":"Parmar MK, Ledermann JA, Colombo N et al (2003) Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4\/AGO-OVAR-2.2 trial. Lancet 361:2099\u20132106","journal-title":"Lancet"},{"key":"5529_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ygyno.2009.04.026","volume":"114","author":"W Meier","year":"2009","unstructured":"Meier W, du Bois A, Reuss A et al (2009) Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum\/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol 114:199\u2013205","journal-title":"Gynecol Oncol"},{"key":"5529_CR30","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1200\/JCO.2009.25.7519","volume":"28","author":"E Pujade-Lauraine","year":"2010","unstructured":"Pujade-Lauraine E, Wagner U, Aavall-Lundqvist E et al (2010) Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse. J Clin Oncol 28:3323\u20133329","journal-title":"J Clin Oncol"},{"key":"5529_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijsu.2015.03.005","volume":"18","author":"V Josa","year":"2015","unstructured":"Josa V, Krzystanek M, Eklund AC et al (2015) Relationship of postoperative thrombocytosis and survival of patients with colorectal cancer. Int J Surg 18:1\u20136","journal-title":"Int J Surg"},{"key":"5529_CR32","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1016\/j.ejca.2014.07.003","volume":"50","author":"G Gakis","year":"2014","unstructured":"Gakis G, Fritsche HM, Hassan F et al (2014) Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy. Eur J Cancer 50:2583\u20132591","journal-title":"Eur J Cancer"},{"key":"5529_CR33","first-page":"237","volume":"39","author":"L Riess","year":"1872","unstructured":"Riess L (1872) Zur pathologischen Anatomie des Blutes. Arch Anat Physiol Wiss Med 39:237\u2013249","journal-title":"Arch Anat Physiol Wiss Med"},{"key":"5529_CR34","volume-title":"Lectures on clinical medicine, delivered at the H\u00f4tel-Dieu, Paris","author":"A Trousseau","year":"1867","unstructured":"Trousseau A, Bazire V, Cormack J (1867) Lectures on clinical medicine, delivered at the H\u00f4tel-Dieu, Paris. R Hardwicke, London"},{"key":"5529_CR35","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.1182\/blood-2012-06-438598","volume":"120","author":"MS Cho","year":"2012","unstructured":"Cho MS, Bottsford-Miller J, Vasquez HG et al (2012) Platelets increase the proliferation of ovarian cancer cells. Blood 120:4869\u20134872","journal-title":"Blood"},{"key":"5529_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B (2011) Contribution of platelets to tumour metastasis. Nat Rev Cancer 11:123\u2013134","journal-title":"Nat Rev Cancer"},{"key":"5529_CR37","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1476-5381.2012.01991.x","volume":"167","author":"A Radziwon-Balicka","year":"2012","unstructured":"Radziwon-Balicka A, Medina C, O'Driscoll L et al (2012) Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance. Br J Pharmacol 167:787\u2013804","journal-title":"Br J Pharmacol"},{"key":"5529_CR38","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ygyno.2013.10.027","volume":"132","author":"K Matsuo","year":"2014","unstructured":"Matsuo K, Nishimura M, Komurov K et al (2014) Platelet-derived growth factor receptor alpha (PDGFR\u03b1) targeting and relevant biomarkers in ovarian carcinoma. Gynecol Oncol 132:166\u2013175","journal-title":"Gynecol Oncol"},{"key":"5529_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/00365590500498166","volume":"40","author":"ON Gofrit","year":"2006","unstructured":"Gofrit ON, Shapiro A, Rund D et al (2006) Postoperative thrombocytosis as a marker for complications after urologic surgery. Scand J Urol Nephrol 40:161\u2013165","journal-title":"Scand J Urol Nephrol"},{"key":"5529_CR40","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1010-7940(05)80172-1","volume":"9","author":"M Schmuziger","year":"1995","unstructured":"Schmuziger M, Christenson JT, Maurice J et al (1995) Reactive thrombocytosis after coronary bypass surgery. An important risk factor. Eur J Cardiothorac Surg 9:393\u2013397","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05529-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-020-05529-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05529-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T23:24:56Z","timestamp":1618010696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-020-05529-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["5529"],"URL":"https:\/\/doi.org\/10.1007\/s00404-020-05529-y","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"type":"print","value":"0932-0067"},{"type":"electronic","value":"1432-0711"}],"subject":[],"published":{"date-parts":[[2020,4,10]]},"assertion":[{"value":"16 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"UC: Grant: Tumorzentrum Dresden, Advisory board: Roche, Astra Zeneca, Honoraria: Roche, Astra Zeneca, Lilly; HJL: advisory board: Amgen, Astra Zeneca, GSK, Lilly, Novartis, Pfizer, Roche, Honoraria: Amgen, Roche, Astra Zeneca, Clovis, GSK, Lilly, Novartis, Pfizer; AB: Advisory board\/ honoraria: Roche, Astra Zeneca, Tesaro; PH: Grants: Tesaro, GSK, Boehringer Ingelheim, Medac, Genmab, Astra Zeneca, Roche, Public funding (ASCO, DKH, DFG), Personal fees: Sotio, Tesaro, Stryker, Zai Lab, MSD, Public funding (ASCO, DKH, DFG), Clovis, Immunogen, Astra Zeneca, Roche; SM: Grants: Astra Zeneca, Medac, MSD, PharmaMar, Roche, Tesaro, Teva, Personal fees: Astra Zeneca, Clovis, Medac, MSD, Novartis, PharmaMar, Roche, Sensor Kinesis, Tesaro, Teva; SK: Personal fees: Roche, Astra Zeneca, Tesaro, PharmaMar, Clovis; PW: Grant: Tumorzentrum Dresden, Advisory board\/ honoraria: Amgen, Astra Zeneca, MSD, Novartis, Pfizer, PharmaMar, Roche, Teva, Eisei, Clovis, Tesaro; NdG: Personal fees: Astra Zeneca, Roche, Amgen, Clovis, MSD, PharmaMar, Travel expenses: Astra Zeneca, Tesaro; AH: Advisory board: PharmaMar, Promedicis, Pierre Fabre, Roche, Tesaro, Honoraria: Astra Zeneca, Celgene, MedConcept, Med update, Medicultus, Pfizer, Promedicis, Pierre Fabre, Roche, Tesaro, Research grant: Celgene; MGM: Personal fees: Astra Zeneca; AEB: Personal fees: Astra Zeneca, Roche, PharmaMar, Olympus, Clovis, Tesaro, Travel expenses: Astra Zeneca, PharmaMar, Olympus, Tesaro; AdB: Advisory board\/ honoraria: Roche, Astra Zeneca, Tesaro, Clovis, Pfizer, Biocad, Genmab, Seattle Genetics, MSD. All other authors declared not to have any conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"As this is a retrospective study this is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}